Anil Ratty

Anil is a biotech veteran with deep expertise in neuroscience and drug development for complex diseases. His career spans early-stage translational research, clinical development, and strategic leadership in neurology-focused programs. He has held R&D leadership roles in CNS drug discovery across academia and biotech startups and is a co-author of peer-reviewed publications on ubiquitin-pathway genomics and targeted protein degradation—key strategies in neurodegeneration research.